Fatal intoxication with tianeptine (Stablon®) by Proença, Paula et al.
www.elsevier.com/locate/forsciint
Forensic Science International 170 (2007) 200–203Case report
Fatal intoxication with tianeptine (Stablon1)
Paula Proenc¸a a,*, Helena Teixeira a,b, Joa˜o Pinheiro a,
Paula V. Monsanto a, Duarte Nuno Vieira a,b
a National Institute of Legal Medicine- Delegation of Coimbra, Largo da Se´ Nova, 3000-213 Coimbra, Portugal
b Faculty of Medicine, University of Coimbra, Largo da Se´ Nova, 3000-213 Coimbra, Portugal
Received 31 August 2006; received in revised form 25 March 2007; accepted 26 March 2007
Available online 13 July 2007AbstractTianeptine (Stablon1), although structurally similar to tricyclic antidepressants, acts by enhancing the reuptake of serotonin. A fatal case is
presented involving a 26-year-old man, found lying in bed with a ‘‘mushroom of foam’’ around his mouth. Empty blister packs of Stablon1 and a
suicide note were found next to the body. A liquid–liquid extraction procedure with n-hexane: ethyl acetate and n-hexane: 2-propanol, followed by
LC-DAD-MS analysis, using positive mode electrospray ionization was performed. The detection limit was 0.001 mg/mL. The toxicological
results revealed the following tianeptine concentrations in the post-mortem samples: blood 5.1 mg/mL; urine 2.0 mg/mL; liver 23 mg/g; stomach
contents 22 mg. Femoral blood analyses also revealed an ethanol concentration of 0.53 g/L. The present method was also developed and validated
for the other post-mortem specimens, since no previous published data had confirmed the post-mortem distribution of tianeptine. The absence of
other suitable direct causes of death (macroscopic or histological) and the positive results achieved with the toxicological analysis led the
pathologist to rule that death was due to an intoxication caused by the suicidal ingestion of tianeptine in combination with alcohol.
# 2007 Elsevier Ireland Ltd. All rights reserved.
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Tianeptine (Stablon1) is a tricyclic compound structurally
similar to imipramine, which has been used as an antidepressant
in certain European countries since 1988 [1]. Although, the
anxiolytic efficacy profile of tianeptine is also similar to
tricyclic antidepressants, it acts by enhancing the reuptake of
serotonin. Tianeptine is completely metabolised by the liver
and is not subject to first-pass metabolism [2]. Tianeptine
differs from most antidepressants in that it is not primarily
metabolised by the hepatic cytochrome P450 system, indicating
less likelihood of drug–drug interactions [3]. Metabolism
occurs mainly by extra renal routes. Its major metabolic
pathway is b-oxidation and the principal metabolites are
propanoic acid (MC3, inactive metabolite) and pentanoic acid
(MC5, active metabolite) [1–4] (Fig. 1). The pharmacokinetics
is linear to the dosage. Less than 3% of the dose is excreted
unchanged in urine and MC5 half-life is 7.2 h. It is eliminated* Corresponding author. Tel.: +351 239854230; fax: +351 239820549.
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doi:10.1016/j.forsciint.2007.03.035partly unchanged by the kidneys and undergoes biotransforma-
tion [2,5–8].
Several methods have been published for the simultaneous
determination of tianeptine and its MC5-metabolite using high
performance liquid chromatography with UV detection [9–11]
and fluorescence detection [12].
In this study, we report a fatal case involving tianeptine,
using a liquid chromatography associated with photodiode
array and the mass spectrometer (LC/DAD/MS) method
developed to detect, confirm and quantify this antidepressant
in post-mortem samples.
2. Case report
A 26-year-old man was found dead in bed in his apartment
by a friend who had not been seen him since the day before.
During an investigation of the scene, empty blister packs of
Stablon1 (tianeptine, 12.5 mg tablets) and a suicide note to his
family were found next to the body.
At the autopsy, a ‘‘mushroom of foam’’ was observed around
the mouth, but no signs of traumatic injuries were registered.
The internal examination was unremarkable except for some
Fig. 1. Metabolic pathways for tianeptine.
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exuberant congestion of the cerebrum and lungs. Interstitial
edema of the heart was found and some myocytes were slightly
wavy and showed contraction bands. These alterations were
attributed to eventual arrhythmia, complicated by cardiac and
pulmonary failure.
Samples of blood (femoral and cardiac), urine, liver and
stomach contents were taken for toxicological analysis.
3. Materials and methods
3.1. Chemicals and reagents
Tianeptine and protriptyline (used as internal standard) were supplied by
Sigma–Aldrich–Chemie GmbH (Steinheim, Germany). Each standard solution
was prepared in acetonitrile (1 mg/mL) and stored at 4 8C. All solvents were
analytical or HPLC-grade and were purchased from E. Merck (Darmstadt,
Germany). Deionised and purified water was obtained using a Milli-Q system
(Millipore, Molsheim, France). The carbonate buffer (pH 10.5) was prepared by
dissolving 4.2 g of NaHCO3 into a 1000 mL volumetric flask and brought to
volume with deionised water. An ammonium acetate buffer 10 mM (0.771 g/L)
was prepared with deionised water with 0.1% of formic acid. The mobile phase
was filtered through a 0.20 mm filter (Schleicher & Schuell) and degassed in an
ultrasonic bath for 15 min just before use. All samples were filtered through a
0.45 mm Millex1-HV filter (Millipore, Bedford, MA) before injection into the
LC/DAD/MS system.
3.2. Instrumentation
The chromatographic system used was a Waters 2695 Alliance System and a
XTerra MSTM C18 reversed-phase column (2.1 mm i.d.  150 mm, 5 mm). The
mobile phase consisted of acetonitrile and 10 mM ammonium acetate buffer
with 0.1% formic acid (pH 3) (30:70, v/v) pumped at a flow rate of 0.3 mL/min.
The column temperature was maintained at 30 8C. The injection volume was
5 mL.
A Waters 996 photodiode array detector (DAD) was operated on a 210–
400 nm wavelength scans with a 1.2 nm resolution. The UV absorbance was
measured at 220 nm.
Instrument control, data acquisition and processing were achieved using
Waters Empower software (Milford, MA).
Mass spectrometry detection (MS) was carried out on a Waters ZQ 2000
single quadrupole mass spectrometer with electrospray ionization (ESI)
performed in positive mode. Full-scan spectra were recorded from m/z
130–700, at a scan time of 1 s and an interscan delay of 0.1 s. The mass
spectra were represented in centroid mode. The other main instrument
settings were: capillary voltage 3.5 kV; cone voltage 40 V; extractor 5 V;
ion energy 0.5; source temperature 150 8C; desolvation temperature
350 8C; cone gas (N2) flow rate 0 L/h and desolvation gas (N2) flow rate
350 L/h.
Quantitation employed the selected ion-recording mode (SIR) using the
most abundant characteristic ion [M + H]+ at m/z 437 for tianeptine and m/z 264
for the internal standard (protriptyline).3.3. Sample preparation
Control and calibration samples were prepared by spiking drug-free blood
post-mortem specimens with standard solutions.
A 1 mL aliquot of whole blood or 1 g of tissue (cut into small pieces) was
spiked with 30 mL of internal standard (10 mg/mL). Then, 0.5 mL of carbonate
buffer (50 mM, pH 10.5) was added to bring the sample to alkaline conditions.
The samples were vortex mixed, and 6 mL of an n-hexane:ethyl acetate (7:3, v/
v) mixture was added. The samples were extracted by rotation for 15 min
following centrifugation at 2000  g for 20 min. The organic layer was
removed and re-extracted with 6 mL of n-hexane: 2-propanol (99:1, v/v)
mixture. The collected organic layers were evaporated to dryness under a
nitrogen gas flow at 40 8C. The sample residue was reconstituted with 250 mL of
acetonitrile and an aliquot (5 mL) was injected into the LC/DAD/MS system.
4. Results and discussion
The blood and urine post-mortem samples were initially
subjected to a qualitative analysis. Screening was performed for
basic, acidic, and neutral drugs and volatiles using standard
chromatographic methods. These methods included gas
chromatography, liquid chromatography and enzyme immu-
noassay. The blood alcohol result (analysed by a headspace GC/
FID technique) was positive (0.53 g/L). No other drugs were
detected in post-mortem blood.
The calibration curve for tianeptine in blood was linear,
ranging from 0.01 to 10 mg/mL (r2 = 0.9993, seven calibration
points, in triplicate). The detection limit of tianeptine in blood
was 0.001 mg/mL (LOD, S/N = 3) and the lower limit of
quantification (LOQ, S/N = 10) was 0.01 mg/mL. Analytical
recovery was tested at concentration levels 0.1, 5 and 10 mg/
mL and was determined by comparing the representative peak
areas of tianeptine extracted from drug-free blood spiked with
the peak area of a methanolic standard of the same
concentration. The mean recovery was 76% with a coefficient
of variation of  5.3%. For intra-day and inter-day precision
determinations, five replicate analyses were performed on
each of the three concentrations studied. The method proved
to be accurate for tianeptine, both in terms of intra-day and
inter-day analysis, with coefficients of variation (CV) of less
than 10%.
Tianeptine was quantified by selected ion-recording of m/z
437 (using m/z 292 as the confirmation ion) and m/z 409 for the
MC5 metabolite. The SIR mass chromatograms and mass
spectrum in SCAN mode (m/z 437) of the tianeptine detected in
the blood sample of our reported case are shown in Fig. 2.
Since the procedure proved to be sensitive, selective and
reproducible, the method developed was applied to the fatal
Fig. 2. SIR mass chromatograms and mass spectrum in SCAN mode (m/z 437), of tianeptine in post-mortem blood sample (reported case).
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analysed. Toxicological results revealed the following tianep-
tine concentrations in the post-mortem samples: cardiac blood
5.1 mg/mL, urine 2.0 mg/mL, liver 23 mg/g and stomach
contents approximately 22 mg (in a volume of 200 mL). The
high concentration in the stomach contents proves acute
tianeptine intoxication. The main pharmacologically active
metabolite MC5 was only detected in the urine and the liver, but
was not quantified due to the lack of adequate reference
standard.
The antidepressant efficacy and favourable tolerability and
pharmacokinetic profiles of tianeptine in patients with
depression [4], including those with chronic alcoholism, have
been shown [13]. Others authors stated that alcohol co-
administration could decrease tianeptine absorption rate and
lower its plasma levels by about 30% [14]. However, in our
case, even assuming the possibility of a decrease in tianeptine’s
absorption by the presence of alcohol, the concentration found
is still high and thus, this absorption decrease percentage
would not be relevant. To our knowledge, only a few cases of
tianeptine abuse have been reported [15–18]. However, there
are no published reports of fatal cases due to thisTable 1
Selected ions, LOD, LOQ and linearity range of tianeptine in blood samples
Selected ions (m/z)
and cone voltage
Limits
(ng/mL)
Linearity
(mg/mL)
R2
Quantitation Confirmation LOD LOQ
437 292 1 10 0.01–10 0.9993
25 V 35 V S/N < 3 R.S.D. < 20%antidepressant. Only a brief statement was found reporting
the quantitative results in post-mortem blood samples of three
acute tianeptine overdoses. Two of these fatal cases had post-
mortem blood tianeptine levels of 4.0 and 4.2 mg/mL (plus
0.8 g/L ethanol) [1]. The tianeptine blood concentrations
achieved by these authors, reporting fatal cases with this
antidepressant, were lower in comparison with our results
Table 1.
The simultaneous analysis and consequent acquisition using
two different detectors, photodiode array and mass spectro-
meter, allowed us to detect this antidepressant with higher
selectivity and specificity. The present method was also
developed and validated for other post-mortem samples, since
no previous published data had confirmed tianeptine post-
mortem tissue distribution. In our case, it was proved that
tianeptine was quantified in high concentrations in all the post-
mortem samples.
The absence of other suitable direct causes of death
(macroscopic or histological) and the positive results achieved
with the toxicological analysis led the pathologist to rule that
death was due to suicidal ingestion of tianeptine in combination
with use of alcohol.
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